Horizon Bancorp’s AbbVie ABBV Stock Holding History

Horizon Bancorp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$291K	Sell	1,338 -362	-21%	-$80.3K	0.14%	54
2025 Q4	$388K	Hold	1,700	–	–	0.19%	39
2025 Q3	$394K	Sell	1,700 -1,200	-41%	-$244K	0.19%	43
2025 Q2	$538K	Buy	2,900 +1,200	+71%	+$223K	0.27%	41
2025 Q1	$356K	Sell	1,700 -150	-8%	-$29.2K	0.2%	37
2024 Q4	$329K	Hold	1,850	–	–	0.16%	41
2024 Q3	$365K	Sell	1,850 -200	-10%	-$37.3K	0.17%	35
2024 Q2	$352K	Sell	2,050 -863	-30%	-$143K	0.17%	37
2024 Q1	$530K	Sell	2,913 -171	-6%	-$29.5K	0.25%	29
2023 Q4	$478K	Buy	3,084 +1,000	+48%	+$146K	0.23%	27
2023 Q3	$311K	Hold	2,084	–	–	0.2%	29
2023 Q2	$281K	Sell	2,084 -424	-17%	-$62.2K	0.18%	26
2023 Q1	$400K	Hold	2,508	–	–	0.26%	10
2022 Q4	$405K	Buy	+2,508	New	+$385K	0.23%	28
2020 Q3	$220K	Buy	2,508 +150	+6%	+$14.1K	0.31%	92
2020 Q2	$232K	Hold	2,358	–	–	0.25%	76
2020 Q1	$180K	Sell	2,358 -4,142	-64%	-$353K	0.28%	95
2019 Q4	$576K	Buy	+6,500	New	+$540K	0.54%	49

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Horizon Bancorp's ABBV Position: Q1 2026 in Review

Horizon Bancorp reduced its AbbVie (ABBV) stake by 21% in Q1 2026, selling an estimated $80.3K and leaving 1,338 shares worth $291K. The position accounts for 0.14% of the portfolio, ranked #54.

Horizon Bancorp first reported a position in ABBV in Q4 2019 and has held it in 18 quarters since. The position peaked at $576K in Q4 2019. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Horizon Bancorp held 1,338 shares of AbbVie worth $291K as of Q1 2026.
Horizon Bancorp sold 362 AbbVie shares in Q1 2026, an estimated $80.3K.
AbbVie made up 0.14% of Horizon Bancorp's portfolio in Q1 2026, its #54 holding.
Horizon Bancorp first reported a position in AbbVie in Q4 2019 and has held it in 18 quarters since.
Horizon Bancorp's AbbVie position peaked at $576K in Q4 2019.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Horizon Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.